STOCK TITAN

Nascent Biotech (NBIO) Net Income by Year

NBIO OTC

Nascent Biotech Inc reported a net loss of $2.1M in fiscal year 2024. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Nascent Biotech Inc has filed alongside them.

FY2024 annual
Net Income -$2.1M
Source SEC Filings Latest period Q1 FY2025, ended Jun 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NBIO Net Income by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18FilingFY17FilingFY16FilingFY15FilingFY14Filing
Net Income-$2.1MN/A-$470Kn/m-$959KN/AN/AN/A$1.1Mn/m-$4.1Mn/m-$2.2MN/A

NBIO Net Income by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22Filing
Net Income-$377KN/A-$205Kn/m-$829Kn/mN/AN/A-$837K-240.2%-$146Kn/mN/A-$407K$597K-$211Kn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Nascent Biotech Inc financials

Frequently Asked Questions

Nascent Biotech Inc reported a net loss of $2.1M in fiscal year 2024.

Nascent Biotech Inc (NBIO) reported -$377K in net income in Q1 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Nascent Biotech Inc (NBIO) reported on that line in every period on record.